Saturday, April 19, 2014 8:44:19 AM
In terms of management the last few months they have brought on board some good people. The new board of directors, management have come from good companies. Some of the big pharma the new employees for AMBS have come from Pharmacyclics, Johnson and Johnson, and Novartis. The CEO had to entice those big executives with either big money or good science to get them to come on aboard on a stock that trades at .08 cents on the OTC. Regardless these executives came on board and they see a change in research on alzheimer's disease with Lympro and MANF.
I guarantee there will be a partnership on Lympro because from what I understand the big pharmaceutical companies that fail Alzheimer's trials do so not because their compound doesn't work but 30% of the patients enrolled skew the data because they don't even have alzheimer's disease. With an accurate test "Lympro" it may be possible to get more accurate data on who really has Alzheimer's or not. So in closing I have bought my shares and I'm ready for a long term story that will continue to be played throughout many years.
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM